Effect of Food Acceptability on Appetite Hormones' Response in Normal Weight vs. Obese Male Subjects

December 19, 2018 updated by: Ammar Olabi, American University of Beirut Medical Center
Male subjects with specific body characteristics were recruited for the study. Subjects did an acceptability test on custard and completed a screening questionnaire. Around 30 subjects (15 with a normal BMI and 15 obese) continued the study. At each test day, fasting blood samples were withdrawn by a registered nurse under sterile conditions. This procedure was followed by ingestion of one of the two meals within a period of 10-15 minutes. Blood samples of 5 ml were collected at fasting and after ingestion of meals. At the end, subjects were given ad lib access to cheese pizza to assess energy intake after the custard preload. Blood analysis for GLP-1, ghrelin, insulin and glucose levels were performed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Male subjects were recruited for the study based on the following criteria: age between 18 and 50, body mass index normal or obese, non-smokers, non-alcoholic, and do not take medications. Subjects did an acceptability test on custard and completed a screening questionnaire. Around 30 subjects (15 with a normal BMI and 15 obese) continued the study. Subjects were randomly assigned to one of two meals. Each of the two meals was ingested after a 3-day adaptation period. The meals had similar macronutrient composition and provided energy equivalent to 30% of the subjects' resting energy expenditure. At each test day, fasting blood samples were withdrawn by a registered nurse under sterile conditions. This procedure was followed by ingestion of one of the two meals within a period of 10-15 minutes. Blood samples of 5 ml were collected at fasting and after ingestion of meals at 15, 30, 60, 120, 180 and 240 minutes. At the end, subjects were given ad lib access to cheese pizza to assess energy intake after the custard preload. Blood analysis for GLP-1, ghrelin, insulin and glucose levels were performed.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Gender: Male
  • Age: 18-50 years
  • Body Mass Index (BMI): 18.5-24.9 kg/m2 or 30-39.9 kg/m2
  • Stable body weight for at least three months before the study with the absence of any form of dieting, food restriction or other abnormal eating behaviors (to minimize the effect of weight change on ghrelin and GLP-1 statuses)
  • Agreement on the acceptability levels of the two versions (high and low acceptability) of custard

Exclusion Criteria:

  • Smoking
  • Substance abuse such as alcohol or drugs
  • Medical or psychological illness
  • Previous gastrointestinal surgery
  • History of weight fluctuation (weight loss of greater than 5% within the past 3 months)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Lean panelists
Lean panelists or normal weight panelists with a BMI between 18.5 and 24.9 Acceptability was assessed
Food samples two formulations (low and high acceptability levels) of custard were used as experimental meals
OTHER: Obese panelists
Obese panelists with a BMI between 25 and 29.9 Acceptability was assessed
Food samples two formulations (low and high acceptability levels) of custard were used as experimental meals

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Food acceptability
Time Frame: Through study completion, an average of 1 year
Food acceptability on a 9 point hedonic scale
Through study completion, an average of 1 year
Ghrelin
Time Frame: Through study completion, an average of 1 year
Ghrelin levels measured with Enzyme-linked immunosorbent assay (ELISA) kit
Through study completion, an average of 1 year
GLP-1
Time Frame: Through study completion, an average of 1 year
GLP-1 levels measured with Enzyme-linked immunosorbent assay (ELISA) kit
Through study completion, an average of 1 year
Insulin
Time Frame: Through study completion, an average of 1 year
Insulin levels measured with Enzyme-linked immunosorbent assay (ELISA) kit
Through study completion, an average of 1 year
Glucose
Time Frame: Through study completion, an average of 1 year
Glucose levels measured using VITROS ECiQ Immunodiagnostic System
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Appetite
Time Frame: Through study completion, an average of 1 year
Appetite score on the visual analogue scale
Through study completion, an average of 1 year
Energy intake at the next meal
Time Frame: Through study completion, an average of 1 year
Measuring quantity of cheese pizza consumed
Through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2016

Primary Completion (ACTUAL)

July 1, 2017

Study Completion (ACTUAL)

September 30, 2017

Study Registration Dates

First Submitted

December 6, 2018

First Submitted That Met QC Criteria

December 17, 2018

First Posted (ACTUAL)

December 19, 2018

Study Record Updates

Last Update Posted (ACTUAL)

December 20, 2018

Last Update Submitted That Met QC Criteria

December 19, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • NUT.AO.20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eating Behavior

Clinical Trials on Acceptability

3
Subscribe